Dymista nasal spray does not currently have FDA approval for marketing in the United States [1]. As of 2025, its regulatory status remains unchanged in this regard [1].
What is Dymista nasal spray used for?
Dymista is a nasal spray that combines fluticasone propionate, an anti-inflammatory corticosteroid, and azelastine hydrochloride, an antihistamine [1]. This combination is intended for the treatment of nasal allergy symptoms, such as sneezing, runny nose, nasal itching, and congestion [1].
Why is Dymista not approved by the FDA?
The FDA has not approved Dymista for marketing in the U.S. due to the applicant's failure to demonstrate substantial evidence of efficacy for the proposed indication [1]. Specifically, the agency found that the clinical trial data submitted did not adequately support the drug's effectiveness [1].
What are the next steps for Dymista?
With the FDA's decision, the path forward for Dymista's potential U.S. market entry is unclear. The applicant would need to conduct further studies and resubmit an application to address the FDA's concerns regarding efficacy [1].
What are alternatives to Dymista for allergy relief?
For individuals seeking relief from nasal allergy symptoms in the U.S., several FDA-approved options are available. These include prescription and over-the-counter nasal sprays containing corticosteroids (like fluticasone propionate alone or other corticosteroids) and antihistamines (like azelastine hydrochloride alone or other antihistamines) [2, 3]. Oral antihistamines and decongestants are also common treatments for allergy symptoms [2, 3].
How do individual components of Dymista work?
Fluticasone propionate works by reducing inflammation in the nasal passages, which helps to alleviate a wide range of allergy symptoms. Azelastine hydrochloride is an H1 antihistamine that blocks the action of histamine, a chemical released during an allergic reaction that causes symptoms like itching and runny nose [1].
Sources:
[1] https://www.drugpatentwatch.com/us/drug/dymista
[2] https://www.yalemedicine.org/conditions/allergic-rhinitis
[3] https://www.mayoclinic.org/diseases-conditions/allergies/diagnosis-treatment/drc-20351503